EHA2023: Stay tuned to immerse yourself once again in the latest news in hematology and its subspecialties:

Cutting-edge evidence-based approaches to diagnosis and treatment, Highly anticipated clinical and translational research data,
Newest developments in innovative techniques, diagnostic tools, and risk-assessment strategies.

EHA2023 knows no bounds and is intended for medical professionals, national hematology societies, patient groups, medical industry, and media worldwide.

For more details – EHA Hybrid Congress